And just to remind ourselves more about leronlimab action on immune system , by an expert ,,,Dr Scott Hansen , about one year ago during one of our conferences,,
Quotes from Dr Hansen below ..
" I have about 25 years experience in the fields of virology , oncology and immunology.
At OHSU , I currently lead one of the largest and prominent non-human primate research labs in the country.
About 2 years ago , March of 2021 Dr Jonah Sacha , a colleague of mine at OHSU , asked me to help with Receptor Occupancy , and Biomarkers analysis for leronlimab on an exploratory basis,
I was BLOWN AWAY by the data we were generating at the lab.
So what I was observing in the laboratory from the experiments I was doing , there was numerous immuno-modulatory effects , including possible immune cell proliferation , calcium signaling , monocyte proliferation , CCR5 receptor STABILIZATION ,.
Can probably go on and on about it .
This isn't just a molecule to prevent HIV , it is much more then that !!!!!.
I was hooked , and ever since , I've been taking a deeper dive into the mechanics of action for the various disease states , including HIV , NASH and cancer ..
I think this is a PHENOMINAL molecule.."
Yes , many of us being in this for some years now , and analyzing different studies , agree , we also think this is a PHENOMINAL molecule !!!!
He said much more then that in his presentation , but today company will try to prove to ALL about immune activation , and controlling inflammation.
And inflammation is a base of majority, if not ALL diseases we know.
So lets start in HIV patients , since we know those patients have unusually severe general inflammation , Lets add to it the transgender women with HIV ,
And leronlimab will be a winner , if study will be done properly , and I believe with Dr Jay involvement , it will be ..
With MOA of leronlimab , it cant be any other way.
IMO.
Lets have a VERY exciting year here.
GLTA longs..
Bullish